Outcome of Board Meeting

October 13, 2026 To, To, Listing Department, The National Stock Exchange of India BSE Limited Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai – 400 001 Bandra – Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai – 400051, NSE Scrip Code: AHCL Sub: Outcome of Board Meeting of ANLON HEALTHCARE LIMITED (“Company”) Respected Sir/Madam, We would like to inform you that the Board of Directors (“Board”) at its Meeting held today i.e. Tuesday, October 13, 2026, has inter-alia considered and approved the following: - Proposal for raising of funds by way of issuance of warrants each convertible into equivalent number of equity shares, to promoters and non-promoter/public investors, on a preferential basis (“Preferential Issue”), for an aggregate amount not exceeding Rs.250,00,00,000/- (Rupees Two Hundred and Fifty Crore Only), in accordance with the Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 as amended (“SEBI ICDR Regulations”), and other applicable laws. The relevant details pursuant to Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), 2015 (“SEBI Listing Regulations”) and additional details as required under the SEBI Master Circular for compliance with the provisions of the SEBI Listing Regulations by listed entities, bearing ref. no. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026, as annexed in Annexure A. Meeting commenced on 05:30 p.m. IST and concluded on 07:30 p.m. IST. You are requested to take the above information on your record. Thanking You. For ANLON HEALTHCARE LIMITED PUNITKUMAR RASADIA MANAGING DIRECTOR DIN: 06696258 ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in Annexure A Details required under Regulation 30 of SEBI Listing Regulations read with HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 The details relating to the issuance of Convertible Equity Warrants on a Preferential Basis as required under Regulation 30 of SEBI Listing Regulations are as follows: Sr. Particulars Details 1 Type of securities proposed to be Warrants fully convertible into equivalent issued (viz. equity shares, number of Equity Shares of face value of convertibles, etc.) Rs.02/- (Rupees Two Only) each 2 Type of issuance (further public Preferential Issue in accordance with offering, rights issue, depository Chapter V of the SEBI ICDR Regulations, receipts (ADR/GDR), qualified read with the companies Act, 2013 and institutions placements, preferential rules made thereunder. allotment etc.) 3 Total number of securities proposed Warrants fully convertible into equivalent to be issued or the total amount for number of Equity Shares of face value of which the securities will be issued Rs.02/- (Rupees Two Only) each, for an (approximately) aggregate amount not exceeding Rs.250 crore. The number of the warrants, price of the Warrants, fixation of date of shareholders meeting and other related matter shall be decided in the ensuing board meeting, in accordance with the provisions of the applicable laws. The preferential issue will be undertaken for cash consideration. 4 In case of preferential issue, the listed entity shall disclose the following additional details to the stock exchange(s): a. Names of the Investors: i) Punitkumar Rameshbhai Rasadia (Promoter) ii) Meet Atulkumar Vachhani (Promoter) iii) Smart Horizon Capital Advisors Private Limited (Public) iv) Ploutos Plus Consultant Private Limited (Public) b. Post allotment of securities-outcome of thesubscription, issue price, allotted price (in case of convertibles); a. Outcome of the subscription Warrants fully convertible into equivalent number of Equity Shares of face value of Rs.02/- (Rupees Two Only) each, for an aggregate amount not exceeding Rs.250 crores. ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in b. issue price, allotted price (in case The price of the Warrants shall be of convertibles) determined at a later stage in accordance with the provisions of the applicable laws. c. number of investors 4 c. In case of convertibles - intimation (i) Each of the warrants are convertible on conversion of securities or on into equivalent number of equity lapse of the tenure of the shares which are pari- passu with instrument. the fully paid-up equity shares of the Company. (ii) On issue, a minimum of 25% of the consideration shall be payable on the date of allotment and balance 75% shall be payable at the time of allotment of equity shares pursuant to the exercise of options against the warrants, in accordance with the SEBI (ICDR) Regulations. (iii) In the event that the proposed allottee does not exercise the option for equity shares against any of the warrants within a period of 18 months from the date of allotment of such warrants or such other period permitted under the SEBI (ICDR) Regulations, the consideration amount payable shall stand forfeited by the Company. d. Any cancellation or termination of Not Applicable proposal for issuance of securities including reasons thereof. ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in